Quotient Biodiagnostics, Inc., a leading player in the biotechnology sector, is headquartered in the United States. Founded in 2012, the company has rapidly established itself in the field of blood diagnostics, focusing on innovative solutions for transfusion medicine. With a commitment to enhancing patient safety, Quotient offers unique products such as the MosaiQ™ platform, which streamlines blood grouping and antibody screening processes. The company operates primarily in North America and Europe, positioning itself as a key provider of advanced diagnostic technologies. Notable achievements include regulatory approvals that have bolstered its market presence. Quotient Biodiagnostics continues to set itself apart through its dedication to quality and innovation, making significant strides in the evolving landscape of medical diagnostics.
We don't have data for Quotient Biodiagnostics, Inc., but we can show you information about their parent organization instead.
View parent company